CVS Health Corp (CVS)
81.09
+1.13 (1.41%)
NYSE · Last Trade: Nov 5th, 4:12 PM EST
Detailed Quote
| Previous Close | 79.96 |
|---|---|
| Open | 81.65 |
| Bid | 81.08 |
| Ask | 81.09 |
| Day's Range | 79.66 - 83.39 |
| 52 Week Range | 69.51 - 110.68 |
| Volume | 15,952,433 |
| Market Cap | 107.00B |
| PE Ratio (TTM) | 9.418 |
| EPS (TTM) | 8.6 |
| Dividend & Yield | 2.660 (3.28%) |
| 1 Month Average Volume | 10,036,509 |
Chart
About CVS Health Corp (CVS)
CVS Health Corp is a diversified healthcare company that operates a vast network of retail pharmacies, providing prescription medications, over-the-counter products, and health and wellness services. In addition to its retail operations, CVS Health also offers pharmacy benefit management services, helping manage prescription drug costs for businesses and health plans. The company is involved in providing health insurance and health services through its various divisions, including a growing presence in digital health solutions and immunization services. By integrating pharmacy services with healthcare delivery, CVS Health aims to enhance patient care and improve health outcomes across the communities it serves. Read More
News & Press Releases
Divesting the company's business units into smaller segments could have significant implications.
Via The Motley Fool · November 5, 2026
CVS Health (NYSE:CVS) plans to separate its retail pharmacy operations from its insurance and pharmacy services businesses, creating two publicly traded companies in a transaction expected to close in the first half of 2028.
The announcement came as the company reported third-quarter 2026 revenue o
Via MarketBeat · November 5, 2026
S&P 500 Top Movers: Gainers and Losers in Today's US Sessionchartmill.com
Via Chartmill · November 4, 2026
Management unveils a plan to split the company into two public businesses.
Via The Motley Fool · November 4, 2026
CVS Health (NYSE:CVS) Earnings Beat Tests Raised Guidance and Healthcare Splitchartmill.com
Via Chartmill · November 4, 2026
Thursday's after hours session: top gainers and losers in the S&P500 indexchartmill.com
Via Chartmill · October 8, 2026
Most-Active S&P 500 Stocks for Nov. 4, 2026chartmill.com
Via Chartmill · November 4, 2026
S&P 500 Top Movers: Nov. 4, 2026 Session Gainers and Loserschartmill.com
Via Chartmill · November 4, 2026
Today's S&P 500 Gap Movers: XYZ and ZBH Lead Gap-Ups, FIS and TRMB Top Gap-Downschartmill.com
Via Chartmill · November 4, 2026
Diversified healthcare company CVS Health (NYSE:CVS) reported revenue ahead of Wall Street’s expectations in Q3 2026, with revenue up 5.4% year on year to $1...
Via StockStory · November 4, 2026
Diversified healthcare company CVS Health (NYSE:CVS) will be reporting results this Wednesday before market open. Here’s what you need to know. CVS Health be...
Via StockStory · November 2, 2026
Alphabet's 12% drop followed search and YouTube misses as Google Cloud beat. Altimetry likes Microsoft, AMD and Generac and avoids CoreWeave and Cipher Digital.
Via MarketBeat · November 2, 2026
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...
Via StockStory · October 30, 2026
CVS Health stock is down 16% from its 52-week high, and it trades at a relatively modest valuation.
Via The Motley Fool · October 26, 2026
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into CVS Health Corporation (“CVS” or the “Company”) (NYSE: CVS).
By Kahn Swick & Foti, LLC · Via Business Wire · October 26, 2026
AINewsBreaks – ECGI Holdings Inc. (OTC: ECGI) Highlights Avanta Acquisition and Growing Opportunities in $5.3 Trillion U.S. Healthcare Market
ECGI Holdings (OTC: ECGI) is featured in an AINewsWire editorial examining the shift toward preventive, coordinated healthcare and the growing role of artificial intelligence in improving patient outcomes and managing costs. The editorial highlights ECGI’s acquisition of Avanta Group, a developing integrated healthcare platform encompassing Medicare Advantage insurance, management services, AI-enabled technology, consumer health and healthcare infrastructure. The acquisition positions ECGI to pursue opportunities in a U.S. healthcare market that reached $5.3 trillion in 2024, with Medicare Advantage payments projected to total $574 billion in 2026. The editorial also discusses the potential for integrated technology and care coordination to improve efficiency, patient engagement and access to services.
Via Investor Brand Network · October 19, 2026
The Future of Healthcare: AI-Powered, Coordinated and Proactive Care
AINewsWire Editorial Coverage : American healthcare is moving from treating illness after it strikes to preventing it before it starts. U.S. health spending reached $5.3 trillion in 2024, and Medicare Advantage now covers 35.2 million people, or 55% of eligible beneficiaries. KFF projects Medicare Advantage payments of $574 billion in 2026, giving health plans a powerful reason to keep members healthy. That shift is opening the door for a new kind of player. ECGI Holdings Inc . (OTC: ECGI) ( profile ) has completed its acquisition of Avanta Group, a developing platform that spans a Medicare Advantage health plan, management services and AI-enabled health technology. The acquisition gives ECGI a direct path into coordinated, proactive care just as the industry is searching for better ways to deliver it. ECGI is working alongside others operating in the U.S. managed healthcare ecosystem, including industry leaders such as United Health Group Inc. (NYSE: UNH), CVS Health Corporation (NYSE: CVS), Elevance Health Inc. (NYSE: ELV) and…
Via Investor Brand Network · October 19, 2026
AUSTIN, Texas, Oct. 19, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: American healthcare is moving from treating illness after it strikes to preventing it before it starts. U.S. health spending reached $5.3 trillion in 2024, and Medicare Advantage now covers 35.2 million people, or 55% of eligible beneficiaries. KFF projects Medicare Advantage payments of $574 billion in 2026, giving health plans a powerful reason to keep members healthy. That shift is opening the door for a new kind of player. ECGI Holdings Inc. (OTC: ECGI) (profile) has completed its acquisition of Avanta Group, a developing platform that spans a Medicare Advantage health plan, management services and AI-enabled health technology. The acquisition gives ECGI a direct path into coordinated, proactive care just as the industry is searching for better ways to deliver it. ECGI is working alongside others operating in the U.S. managed healthcare ecosystem, including industry leaders such as United Health Group Inc. (NYSE: UNH), CVS Health Corporation (NYSE: CVS), Elevance Health Inc. (NYSE: ELV) and Humana Inc. (NYSE: HUM).
By AINewsWire · Via GlobeNewswire · October 19, 2026
Get insights into the top movers in the S&P500 index of Friday's pre-market session.chartmill.com
Via Chartmill · October 9, 2026
Exploring the top movers within the S&P500 index during today's session.chartmill.com
Via Chartmill · October 7, 2026
Wednesday's session: top gainers and losers in the S&P500 indexchartmill.com
Via Chartmill · October 7, 2026
Treasuries pay more today, but these three healthcare dividend payers offer something Treasuries can't: growth in both the payout and the stock.
Via The Motley Fool · October 1, 2026
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into CVS Health Corporation (“CVS” or the “Company”) (NYSE: CVS).
By Kahn Swick & Foti, LLC · Via Business Wire · September 28, 2026
Income investors now have a choice they haven't had to make in nearly two decades.
Via The Motley Fool · September 26, 2026
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...
Via StockStory · September 23, 2026